ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $825 | -15.7% | 1,058 | 0.0% | 0.00% | – |
| Q2 2023 | $979 | -94.6% | 1,058 | -93.4% | 0.00% | – |
| Q3 2022 | $18,000 | +800.0% | 16,049 | +1345.9% | 0.00% | – |
| Q2 2022 | $2,000 | -90.9% | 1,110 | -89.4% | 0.00% | – |
| Q1 2022 | $22,000 | +29.4% | 10,477 | +135.5% | 0.00% | – |
| Q4 2021 | $17,000 | -41.4% | 4,449 | -22.3% | 0.00% | – |
| Q3 2021 | $29,000 | +480.0% | 5,729 | +403.0% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 1,139 | -14.2% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 1,327 | -7.6% | 0.00% | – |
| Q4 2020 | $7,000 | -53.3% | 1,436 | -24.7% | 0.00% | – |
| Q3 2020 | $15,000 | +7.1% | 1,907 | +40.4% | 0.00% | – |
| Q2 2020 | $14,000 | +180.0% | 1,358 | -31.2% | 0.00% | – |
| Q1 2020 | $5,000 | – | 1,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |